Indian Immunologicals launches Measles and Rubella vaccine for children

Indian Immunologicals launches Measles and Rubella vaccine for children

Hyderabad-based Indian Immunologicals Limited (IIL) has launched Mabella (Measles and Rubella) vaccine for children, developed in partnership with Polyvac Institute, Vietnam. Through rigorous human clinical trials, Mabella has demonstrated both safety and effectiveness. This launch took place along with Human Biologicals Institute (HBI), a branch of IIL, marking its 25th anniversary since its establishment in 1998. …

Read more

New Measles and Rubella Vaccine Found to be Safe and Effective

New Measles and Rubella Vaccine Found to be Safe and Effective

A study from India found that Mebella is well tolerated in healthy people between 9 months to 49 years old, and works as well as MR-VAC.1 While measles and rubella usually resolve on their own for most people, there can be severe complications for these vaccine-preventable diseases. Measles is a leader in child mortality across …

Read more